investorscraft@gmail.com

Intrinsic Value of Healthpeak Properties, Inc. (DOC)

Previous Close$18.54
Intrinsic Value
Upside potential
Previous Close
$18.54

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Healthpeak Properties, Inc. is a leading real estate investment trust (REIT) specializing in healthcare-related properties, including life science facilities, medical offices, and senior housing. The company generates revenue primarily through long-term leases with high-quality tenants such as research institutions, hospitals, and senior care operators. Its diversified portfolio is strategically located in high-demand markets, ensuring stable cash flows and occupancy rates. Healthpeak’s focus on mission-critical healthcare assets positions it as a resilient player in the REIT sector, benefiting from demographic trends like aging populations and increased biotech innovation. The company’s emphasis on life science labs—a high-growth segment—further strengthens its competitive edge. By maintaining strong tenant relationships and disciplined capital allocation, Healthpeak sustains its reputation as a reliable income generator with moderate growth potential.

Revenue Profitability And Efficiency

Healthpeak reported revenue of $2.70 billion for FY 2024, with net income of $243.1 million, translating to diluted EPS of $0.36. Operating cash flow stood at $1.07 billion, reflecting efficient property management and lease execution. The absence of capital expenditures suggests a focus on optimizing existing assets rather than aggressive expansion. The company’s ability to convert revenue into cash flow underscores its operational discipline.

Earnings Power And Capital Efficiency

With an operating cash flow margin of approximately 40%, Healthpeak demonstrates strong earnings power. The REIT’s capital efficiency is evident in its ability to sustain dividends while managing a sizable debt load. The lack of capex indicates a mature portfolio, though reinvestment may be necessary to maintain competitiveness in evolving healthcare real estate markets.

Balance Sheet And Financial Health

Healthpeak’s balance sheet shows $119.8 million in cash against total debt of $9.02 billion, indicating significant leverage. However, the REIT’s stable cash flows and long-term lease structures mitigate liquidity risks. The debt level is typical for the sector but requires careful monitoring amid rising interest rates. Shareholders’ equity remains supported by high-quality assets.

Growth Trends And Dividend Policy

The company’s growth is tied to organic lease escalations and selective acquisitions in life sciences. A dividend of $1.18 per share reflects a commitment to income-focused investors, though payout ratios should be evaluated against FFO sustainability. Demographic tailwinds in healthcare demand provide a favorable backdrop for steady, long-term growth.

Valuation And Market Expectations

Healthpeak’s valuation likely reflects its stable cash flows and sector tailwinds, though high leverage may temper multiples. Market expectations appear balanced, pricing in moderate growth with a focus on dividend reliability. Comparables in the healthcare REIT space suggest investor confidence in its niche positioning.

Strategic Advantages And Outlook

Healthpeak’s strategic advantages include its focus on recession-resistant healthcare assets and a diversified tenant base. The outlook remains positive, supported by secular demand for life science and medical office spaces. Challenges include debt management and competitive pressures in high-growth markets. Prudent capital allocation will be key to sustaining long-term value creation.

Sources

Company filings (10-K), investor presentations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount